-
Inter and intra - tumor heterogeneity in Colorectal Cancer
Study
EGAS00001002150
-
Whole Exome Sequencing of Localized Prostate Cancer Patients
Study
EGAS00001005685
-
Angiosarcoma_RNA_sequencing
Study
EGAS00001000590
-
Preclinical_evolution_of_haematological_malignancies_
Study
EGAS00001002128
-
Scalable whole-genome single-cell library preparation without pre-amplification
Study
EGAS00001002170
-
Novel Epigenetic Markers for Toxicity after Intraoperative and Conventional Radiotherapy for Breast Cancer
Study
EGAS00001001279
-
RNA seq on 19 samples of Radiation-Induced Meningiomas
Study
EGAS00001002318
-
Mosaic_Colorectal_Metastasis
Study
EGAS00001000613
-
TMD_AMKL_targeted_follow_up
Study
EGAS00001000569
-
CancerLocator: Non-Invasive Cancer Diagnosis and Tissue-of-Origin Prediction Using Methylation Profiles of Cell-Free DNA
Study
EGAS00001002211
-
Clinical Cancer Genomic Profiling by Three-Platform Sequencing of Whole Genome, Whole Exome and Transcriptome
Study
EGAS00001002217
-
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer
Study
EGAS00001003233
-
ExomeSeq Neoantigen Immunogenicity Landscapes
Study
EGAS00001007508
-
Divergence between high metastatic tumor burden and low circulating tumor DNA concentration in metastasized breast cancer
Study
EGAS00001000625
-
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000001760
-
Poly(A) RNA sequencing of hepatocellular carcinoma tumors and their matched noncancerous liver tissues
Study
EGAS00001002337
-
Patient-derived organoids as predictive models for drug testing and repurposing in glioblastoma therapy
Study
EGAS50000001221
-
Phenotypic characterization and prognostic impact of CD103+ tissue-resident memory T cells in diffuse large B cell lymphoma
Study
EGAS50000000943
-
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Study
EGAS00001002390
-
The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer
Study
EGAS00001001305
-
Linked-Read Whole Genome Sequencing Profiles Structural Variant Landscape of Gliomas with Barcode-Level Evidence
Study
EGAS50000000947
-
Cisplatin increases sensitivity to FGFR inhibition in patient-derived xenograft models of lung squamous cell carcinoma
Study
EGAS00001002423
-
Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer
Study
EGAS50000000923
-
Recurrent epimutations activate gene body promoters in primary glioblastoma
Study
EGAS00001000685
-
Employing_single_cell_sequencing_for_detection_of_mutational_signatures_reflecting_on_going_mutagenesis_
Study
EGAS00001002679
-
Genetic alterations in metastatic uveal melanoma
Study
EGAS00001003303
-
Lung_Cancer_Whole_Genomes
Study
EGAS00001000148
-
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients (LuCaP cell line data)
Study
EGAS50000000917
-
High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tube
Study
EGAS00001002589
-
APOBEC3 mutagenesis drives therapy resistance in breast cancer
Study
EGAS50000000875
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
Metastatic_Prostate_Follow_Up
Study
EGAS00001000730
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue
Study
EGAS00001000737
-
Expression profiles of DLL1 positive and negative subpopulations in metastatic colorectal cancer organoids under cetuximab treatment
Study
EGAS50000001780
-
Whole Exome Sequencing of Human Gastro-esophageal Cancer PDXs
Study
EGAS50000000966
-
Germline alterations of acute myeloid leukemia
Study
EGAS00001002760
-
Whole exome and transcriptome sequencing of biliary tract cancer
Study
EGAS00001000950
-
Drug screening and whole genome sequencing of primary cells and cell lines from ovarian cancer patients to associate genomic aberrations with in vitro drug sensitivities
Study
EGAS00001002239
-
MutWP6__CRUK_Grand_Challenge_Mutographs_of_Cancer__Botseq
Study
EGAS00001004330
-
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
Study
EGAS00001003886
-
EBV_AID_project
Study
EGAS00001000955
-
Genomic landscape of oral cancers (Illumina RNA-Seq)
Study
EGAS00001003237
-
Xenograft_Sequencing
Study
EGAS00001000140
-
Low T cell diversity is associated with poor outcome in bladder cancer - Total RNAseq data
Study
EGAS50000000939
-
Low T cell diversity is associated with poor outcome in bladder cancer - Single cell RNAseq and TCRseq data
Study
EGAS50000000938
-
Low T cell diversity is associated with poor outcome in bladder cancer - Bulk TCRseq data
Study
EGAS50000000940
-
Colorectal advanced adenomas NKI-AvL TGO COCOS series
Study
EGAS00001002952
-
Somatic_mutation_and_clonal_evolution_normal_breast_tissue_TGS
Study
EGAS00001002858
-
Genome analysis of oesophageal cancer and Barrett's oesophagus
Study
EGAS00001002864